USANA Health Sciences, Inc. (USNA) 股票分析

公司概述

USANA Health Sciences, Inc. operates within the consumer defensive sector as a packaged foods manufacturer, specifically developing and selling science-based nutritional, personal care, and skincare products across the Asia Pacific, the Americas, and Europe regions. The company organizes its operations into two distinct segments: Core nutritional and Hiya Direct-To-Consumer, which allows for a diversified approach to market penetration. In terms of scale, the enterprise holds a market capitalization of $333.52M while generating annual revenue of $925.26M with a workforce of 1570 employees. These financial metrics indicate a mid-sized enterprise that maintains a significant revenue base relative to its market cap, suggesting a valuation that places a lower multiple on its sales compared to many high-growth technology peers. The disparity between the $925.26M revenue and the $333.52M market cap highlights a market perception that factors in the company's low profit margins and capital-intensive nature when determining equity value.

财务健康

The company reported a trailing twelve-month revenue of $925.26M alongside a net income of $10.76M and an EBITDA of $83.42M, revealing a substantial gap between top-line sales and bottom-line earnings that points to a cost structure heavily impacted by operating expenses and potentially significant tax or interest costs. This structural reality is further evidenced by the free cash flow of $36.85M, which represents the cash generated after capital expenditures and serves as a critical indicator of the company's financial flexibility to fund operations without relying solely on external financing. Margin analysis shows a gross margin of 78.3%, indicating strong pricing power or low cost of goods sold, while the operating margin of 7.6% and profit margin of 1.2% demonstrate that a large portion of revenue is consumed by operating leverage and other expenses before reaching the bottom line. The balance sheet exhibits a conservative profile with cash holdings of $158.38M significantly exceeding total debt of $31.96M, supported by a debt-to-equity ratio of 5.45 which, despite appearing high, is mitigated by the substantial cash cushion. Liquidity is robust as indicated by a current ratio of 2.24, suggesting the company holds more than double the current assets required to cover its short-term liabilities. Return metrics show a return on equity of 2.0% and a return on assets of 4.3%, figures that reveal management effectiveness is currently constrained, generating modest returns on the capital employed and the asset base.

估值评估

The trailing P/E ratio stands at 31.16 while the forward P/E is significantly lower at 6.52, implying that the market currently prices in a substantial decline in future earnings or expects the current high valuation to compress rapidly in the coming period. The price-to-book ratio of 0.62 indicates that the stock is trading well below its book value, suggesting the market views the company's assets as overvalued on a balance sheet basis or that the book value does not capture the full potential of its intangible assets. Alternative valuation metrics such as the price-to-sales ratio of 0.36 and the EV/EBITDA of 3.12 suggest the company is valued at a very low multiple relative to its sales and earnings power, reflecting skepticism regarding its ability to convert sales into sustainable profits. Regarding price metrics, the stock has a 52-week high of $38.32 and a 52-week low of $16.60, meaning the current price sits at a level where the historical volatility has created a wide trading range over the last year. The beta value of 0.70 indicates that the stock price is less volatile than the broader market, moving with roughly 30% less intensity than the overall index during periods of market fluctuation.

Growth & Income

The revenue growth rate over the last year is 5.9%, whereas the earnings growth rate is listed as N/A, which implies that the company has not reported consistent or sufficient earnings to calculate a year-over-year percentage, often seen in firms with cyclical or volatile profitability patterns. Because the company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it does not distribute cash to shareholders, meaning all available earnings are retained within the business for reinvestment rather than being paid out. This reinvestment strategy is typical for companies prioritizing growth capital accumulation over immediate income generation, although the low profit margins suggest limited free cash available for expansion projects. The overall growth and income profile is characterized by steady top-line expansion of nearly 6% but a lack of earnings growth visibility and a complete absence of dividend income for investors seeking current yield.